One option to attenuate TNF-α is to use an antibody approach to inhibit and clear TNF-α before it could reach its target [44,49,50]; this has effectively been achieved in the treatment of rheumatoid arthritis. The gene discussed is TNF; the disease is rheumatoid arthritis.